Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2006 5
2007 9
2008 4
2009 4
2010 8
2011 1
2012 4
2013 1
2014 4
2015 3
2016 6
2017 3
2018 31
2019 20
2020 27
2021 20
2022 8
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Loricrin Protects against Chemical Carcinogenesis.
Ogawa T, Ishitsuka Y, Nakamura Y, Watanabe R, Okiyama N, Fujisawa Y, Fujimoto M, Roop DR, Nomura T. Ogawa T, et al. Among authors: watanabe r. J Invest Dermatol. 2022 Jul;142(7):2023-2026.e1. doi: 10.1016/j.jid.2021.12.015. Epub 2021 Dec 27. J Invest Dermatol. 2022. PMID: 34968502 Free article. No abstract available.
Eribulin mesylate exerts antitumor effects via CD103.
Oya K, Nakamura Y, Watanabe R, Tanaka R, Ichimura Y, Kubota N, Matsumura Y, Tahara H, Okiyama N, Fujimoto M, Nomura T, Fujisawa Y. Oya K, et al. Among authors: watanabe r. Oncoimmunology. 2023 May 27;12(1):2218782. doi: 10.1080/2162402X.2023.2218782. eCollection 2023. Oncoimmunology. 2023. PMID: 37261089 Free PMC article.
Loricrin and NRF2 Coordinate Cornification.
Ishitsuka Y, Ogawa T, Nakamura Y, Kubota N, Fujisawa Y, Watanabe R, Okiyama N, Fujimoto M, Roop DR, Ishida-Yamamoto A. Ishitsuka Y, et al. Among authors: watanabe r. JID Innov. 2021 Oct 15;2(1):100065. doi: 10.1016/j.xjidi.2021.100065. eCollection 2022 Jan. JID Innov. 2021. PMID: 35024686 Free PMC article.
Recent advances in dermatomyositis-specific autoantibodies.
Fujimoto M, Watanabe R, Ishitsuka Y, Okiyama N. Fujimoto M, et al. Among authors: watanabe r. Curr Opin Rheumatol. 2016 Nov;28(6):636-44. doi: 10.1097/BOR.0000000000000329. Curr Opin Rheumatol. 2016. PMID: 27533321 Review.
Papulonodular lesions in Erdheim-Chester disease.
Oya K, Ishitsuka Y, Nakamura Y, Watanabe R, Okiyama N, Fujimoto M, Fujisawa Y. Oya K, et al. Among authors: watanabe r. J Dermatol. 2021 Sep;48(9):e445-e446. doi: 10.1111/1346-8138.16005. Epub 2021 Jun 2. J Dermatol. 2021. PMID: 34080226 No abstract available.
Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis.
Okiyama N, Ichimura Y, Shobo M, Tanaka R, Kubota N, Saito A, Ishitsuka Y, Watanabe R, Fujisawa Y, Nakamura Y, Murakami A, Kayama H, Takeda K, Fujimoto M. Okiyama N, et al. Among authors: watanabe r. Ann Rheum Dis. 2021 Sep;80(9):1201-1208. doi: 10.1136/annrheumdis-2020-218661. Epub 2021 Apr 2. Ann Rheum Dis. 2021. PMID: 33811031
143 results